Adagio Medical (ADGM) grants director Sean Salmon 30,000 stock options
Rhea-AI Filing Summary
Adagio Medical Holdings, Inc. director Sean Salmon received a grant of 30,000 non-qualified stock options to buy common stock. The options have an exercise price of $0.7103 per share, expire on June 16, 2036, and will vest in 12 equal monthly installments over one year starting June 16, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Salmon Sean
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Non-qualified stock option (right to buy) F1 | 30,000 | $0.00 | $0.00 |
Holdings After Transaction:
Non-qualified stock option (right to buy) — 30,000 shares (Direct)
Footnotes (1)
- F1. Annual stock option granted under the Issuer's Non-Employee Director Compensation Policy and the Issuer's 2024 Equity Incentive Plan (the "Option"). The Option will vest in equal monthly installments over a one-year period, whereby 1/12th of shares underlying the Option shall vest in equal monthly installments at the conclusion of each month of continuous service after the vesting commencement date of 06/16/2026.
Key Figures
Options granted: 30,000 shares
Exercise price: $0.7103 per share
Expiration date: 2036-06-16
+3 more
6 metrics
Options granted
30,000 shares
Non-qualified stock option grant to director Sean Salmon on 2026-06-16
Exercise price
$0.7103 per share
Conversion or exercise price of granted non-qualified stock options
Expiration date
2036-06-16
Option expiration for the 30,000-share non-qualified stock option grant
Underlying shares
30,000 shares
Common stock underlying the non-qualified stock option grant
Post-transaction holdings
30,000 options
Total derivative holdings reported following the transaction
Vesting period
1 year
Monthly vesting in 12 equal installments after 06/16/2026
Key Terms
Non-qualified stock option, Equity Incentive Plan, Non-Employee Director Compensation Policy, vesting commencement date
4 terms
Non-qualified stock option financial
"Non-qualified stock option (right to buy)"
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
Equity Incentive Plan financial
"the Issuer's 2024 Equity Incentive Plan (the "Option")."
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
Non-Employee Director Compensation Policy financial
"under the Issuer's Non-Employee Director Compensation Policy"
vesting commencement date financial
"after the vesting commencement date of 06/16/2026."
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
FAQ
What insider transaction did Adagio Medical Holdings (ADGM) report for Sean Salmon?
Adagio Medical Holdings reported that director Sean Salmon received a grant of 30,000 non-qualified stock options on June 16, 2026. These options give him the right to purchase common stock at a fixed exercise price, subject to the vesting schedule disclosed.
What is the exercise price of the new stock options granted to Sean Salmon at ADGM?
The granted options have an exercise price of $0.7103 per share. This price is the amount payable per share if the options are exercised in the future, assuming the options have vested and remain outstanding under the plan terms.
How many Adagio Medical (ADGM) options does Sean Salmon hold after this transaction?
Following this grant, Sean Salmon holds 30,000 non-qualified stock options as reported. This entire amount comes from the June 16, 2026 award and reflects his direct derivative holdings shown in the ownership table after the transaction.
What is the vesting schedule for Sean Salmon’s new ADGM stock options?
The options vest over one year in 12 equal monthly installments. Specifically, 1/12 of the 30,000 shares vests at the end of each month of continuous service after the vesting commencement date of June 16, 2026.
When do Sean Salmon’s new Adagio Medical (ADGM) options expire?
The non-qualified stock options granted to Sean Salmon expire on June 16, 2036. After this expiration date, any unexercised portion of the 30,000-share option grant will no longer be exercisable under the plan.
Under what plans were Sean Salmon’s ADGM options granted?
The options were issued as an annual stock option grant under Adagio Medical’s Non-Employee Director Compensation Policy and its 2024 Equity Incentive Plan, as described in the footnote to the reported transaction.
AI-generated analysis. How Rhea-AI works. Not financial advice.
